Italy's Garofalo Health Care Q1 revenue rises 3.2%, helped by acquisition

Garofalo Health Care

14/05/2026 10:27

Overview

Italy healthcare provider's Q1 revenue rose 3.2% yr/yr to EUR 132.7 mln

Net income fell to EUR 8.4 mln from EUR 10.1 mln yr/yr, mainly on higher amortization

Q1 results include contribution from Casa di Cura Città di Roma, acquired January 2026

Outlook

Company expects to continue accredited activities and invest in structural and technological upgrades

Company plans further integration of Città di Roma and expansion of private patient services

Company will continue significant investments in expansion and new technology

Result Drivers

AURELIA GROUP PERFORMANCE - Co said revenue growth was driven by Aurelia group, which saw a 4.1% yr/yr increase excluding acquisition effects

ACQUISITION IMPACT - Casa di Cura Città di Roma, acquired in January, contributed EUR 4.3 mln to Q1 revenue

HIGHER AMORTIZATION - Net income declined due to increased amortization and asset revaluations

Company press release: ID:nBIA9nh7Gc

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 132.7 mln
Q1 Net Income
EUR 8.4 mln


Analyst Coverage

The one available analyst rating on the shares is "strong buy"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for Garofalo Health Care SpA is €5.90, about 11.7% above its May 13 closing price of €5.28

The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 17 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)